06/07/2026
For those following along with our PTAS Journey. This was the response I received. I feel like we have not been heard and this is what I have replied….
Dear Hon Bridget Archer MP,
Thank you for taking the time to respond to my correspondence regarding the Patient Travel Assistance Scheme (PTAS) and for acknowledging the complexity of Sophia’s medical condition. I appreciate your recognition that families caring for children with lifelong, complex medical needs face significant challenges.
However, I feel that the central concern I raised has not been addressed.
My letter was not simply about one PTAS application. It was about the suitability of the current PTAS process for children with permanent, lifelong conditions who require ongoing interstate specialist care.
Sophia has Apert syndrome. This is a lifelong genetic condition that will never change. She has been under the care of the Royal Children’s Hospital in Melbourne since birth and has undergone more than 50 procedures. She is treated by numerous specialist teams including ENT, Craniofacial, Plastic Surgery, Respiratory, Dental, Neurosurgery and others. This level of care will continue throughout her childhood and into adulthood.
The current PTAS process requires us to repeatedly obtain new referrals and complete separate applications for each specialist every 12 months. While I understand the importance of accountability for public funding, this approach places an enormous and unnecessary burden on families and on our already stretched healthcare system.
Every year we must return to our paediatrician simply to have referrals rewritten for specialists who have treated Sophia for many years. These appointments take valuable time away from other patients who genuinely need to see their paediatrician for diagnosis or treatment. The paediatrician must then spend additional time preparing referrals and completing paperwork that provides little new clinical information because Sophia’s diagnosis and need for specialist care have not changed.
The administrative burden does not end there. As parents, we are then required to complete numerous PTAS applications—often close to ten separate forms—because each Melbourne specialist requires an individual referral and assessment. This means repeatedly providing the same information, despite the Department already having extensive records confirming Sophia’s lifelong diagnosis and ongoing need for interstate multidisciplinary care.
This process consumes valuable time for families, medical practitioners and PTAS staff alike. It is difficult to see how repeatedly recreating the same paperwork each year represents the most efficient or effective use of limited healthcare resources.
I was encouraged to read that the Department is reviewing PTAS processes. I sincerely hope that this review considers more practical arrangements for patients with permanent, lifelong conditions.
For children like Sophia, it would seem far more appropriate to allow a long-term approval or a simplified renewal process that recognises an established diagnosis and ongoing specialist treatment plan. This would reduce unnecessary administrative work, ease pressure on paediatricians and hospital staff, improve efficiency within PTAS, and allow families to focus on caring for their children rather than navigating repetitive paperwork.
I respectfully ask that this issue be genuinely considered as part of the current review. Families managing lifelong complex conditions deserve a system that recognises the reality of their circumstances rather than requiring them to repeatedly prove what is already well established.
Thank you again for your response and for considering my feedback. I hope that meaningful changes can be made so that future families experience a system that supports them rather than adding to the challenges they already face.
Yours sincerely
Anita ILES